Massachusetts General Hospital- MGH
Boston, Massachusetts 02215
8 studies enrolling now · 33 studies all time
What they study most
4H Syndrome, ADLD, AGS, ALD, ALD (Adrenoleukodystrophy), ALD Gene Mutation, ALSP, AMN, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse
Studies at this site
- A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas — Recruiting now
- Addressing Emotional Distress in Dyads of Persons With a Young Onset Dementia (YOD) and Their Care-partners — Recruiting now
- A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors — Recruiting now
- Novel Digital Application for Patients With Acute Leukemia — Recruiting now
- The Myelin Disorders Biorepository Project — Recruiting now
- Rare and Atypical Diabetes Network — Recruiting now
- Parkinson's Foundation PD GENEration Genetic Registry — Recruiting now
- Building Resiliency in Dyads of Patients With an ANI Admitted to the Neuro-ICU and Their Informal Caregivers — Running, not enrolling
- Multi-site Feasibility of an Integrated Treatment for the Biology and Experience of Depression: The MULTIBED Study — Starting soon
- A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence — Running, not enrolling
- Tele-Palliative Care Intervention for Patients With Chronic Graft-Versus-Host Disease — Running, not enrolling
- Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF — Running, not enrolling
- ADVENT Trial Long Term Outcomes Evaluating Atrial Fibrillation Progression Study — Completed
- Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma — Running, not enrolling
- Web-based Mind-body Program for Comorbid Nontraumatic Upper-extremity Condition and Risky Substance Use — Completed
- A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101) — Completed
- DS-8201a in HER2-positive Gastric Cancer That Cannot Be Surgically Removed or Has Spread (DESTINY-Gastric02) — Completed
- The FARAPULSE ADVENT PIVOTAL Trial PFA System vs SOC Ablation for Paroxysmal Atrial Fibrillation — Completed
- Study Assessing Safety and Efficacy of Combination of BL-8040 and Pembrolizumab in Metastatic Pancreatic Cancer Patients — Completed
- Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+) — Status unconfirmed
- Study to Assess Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL or CLL — Stopped early
- Oral Paclitaxel Efficacy Safety and PK in Recurrent and Metastatic Breast Cancer — Completed
- First-in-human Study of Oral TP-0184 in Patients With Advanced Solid Tumors — Completed
- Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors — Stopped early
- Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566 — Completed
- Phase I Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of BVD-523 in Patients With Advanced Malignancies — Completed
- A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women — Completed
- Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma — Completed
- A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia — Completed
- Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy — Completed
- Efficacy Study of Light Therapy as an Adjunctive Treatment for Parkinson's Disease — Completed
- Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia — Completed
- Effects of Blood Transfusion in Healthy Volunteers — Completed